Agilent Technologies acquires specific assets of A2 Technologies

Download PDF Copy

Editorial Checklist

Reviewed

Agilent Technologies Inc.Feb 10 2011

Agilent Technologies Inc. (NYSE: A) has completed the acquisition of specific assets of A2 Technologies. Financial details were not disclosed for the acquisition, which was first announced Jan. 19.

The acquisition supports Agilent's goal of expanding its spectroscopy business. Substantially all of A2 Technologies' intellectual property, technology and spectroscopy product portfolio are now part of Agilent's Spectroscopy Solutions Division within its Chemical Analysis Group. All former A2 Technologies employees have joined Agilent.

Source:

Agilent Technologies Inc.

Posted in: Business / Finance

Tags: Chemical Analysis, Spectroscopy, Technology

Comments (0)

Download PDF Copy

Suggested Reading

Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking

Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking

Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors

Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Revolutionizing brain tumor treatment: the rise of AI in neuro-oncology

Revolutionizing brain tumor treatment: the rise of AI in neuro-oncology

How Infrared Microscopy Can Solve Classic Histopathology Problems

How Infrared Microscopy Can Solve Classic Histopathology Problems

Study links higher microplastic levels in urine to endometriosis risk

Study links higher microplastic levels in urine to endometriosis risk

High levels of microplastics found in prostate tumors, possibly linked to take-out food

High levels of microplastics found in prostate tumors, possibly linked to take-out food

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Utilizing process Raman in optimizing cultivated meat production